ENVALITH
大研医器株式会社 logo

DAIKEN MEDICAL CO.,LTD.

7775Standard MarketPrecision Instruments

大研医器株式会社 logo
DAIKEN MEDICAL CO.,LTD.7775

Governance

A company with a Board of Corporate Auditors. The Board of Directors consists of 4 directors (2 of whom are outside directors), and the Board of Corporate Auditors consists of 3 auditors (2 of whom are outside auditors). A Management Strategy Meeting chaired by an outside director is held monthly, and the Board of Directors met 13 times in FY2026 (ending March 2026).

Outside Director Ratio

50.0%

Nomination Committee

Established

Compensation Committee

Established

Risk Management

The Company has established an Internal Control Committee chaired by the Representative Director and President, with a structure in place under which each department head identifies and reports risks on a routine basis. Company-wide risks, including climate-related risks, are integrated into the internal control system and are continuously monitored by the internal audit department.

Shareholder Returns

The company's basic policy is a payout ratio of 60% or more, with dividends paid twice a year (interim and year-end). The annual dividend for FY2026 (ending March 2026) is ¥20 per share (¥9 interim + ¥11 year-end), with a payout ratio of 62.3%. The same amount of ¥20 is planned for FY2027 (ending March 2027) (forecast payout ratio of 97.4%).

Dividend Policy

The basic policy is profit distribution based on stable dividends with a payout ratio of 60% or more, implemented twice a year as an interim dividend and a year-end dividend. For FY2026 (ending March 2026), the annual dividend per share is ¥20 (¥9 interim + ¥11 year-end), with total dividends of ¥574 million and a payout ratio of 62.3%. For FY2027 (ending March 2027), an annual dividend of ¥20 (¥9 interim + ¥11 year-end, forecast payout ratio of 97.4%) is planned. The articles of incorporation stipulate flexible dividend implementation by resolution of the Board of Directors.

Dividend

Paying

Share Buyback

None

Shareholder Benefits

None

ESG

Based on ISSB standards, which succeeded TCFD, the company analyzes and discloses climate change risks and opportunities under two scenarios: 1.5°C and 4°C. Total GHG emissions for FY2024 were 23,189 t-CO2 (Scope 3 accounted for approximately 94.7%), a slight decrease year on year. Regarding human capital, the company disclosed a female manager ratio of 7.7% (2027 target: 15%) and a male childcare leave uptake rate of 28.6% (target: 50%).

Last updated: June 17, 2026